Isoflurane post-treatment ameliorates GMH-induced brain injury in neonatal rats

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND AND PURPOSE - This study investigated whether isoflurane ameliorates neurological sequelae after germinal matrix hemorrhage (GMH) through activation of the cytoprotective sphingosine kinase/sphingosine-1-phosphate receptor/Akt pathway. METHODS - GMH was induced in P7 rat pups by intraparenchymal infusion of bacterial collagenase (0.3 U) into the right hemispheric germinal matrix. GMH animals received 2% isoflurane either once 1 hour after surgery or every 12 hours for 3 days. Isoflurane treatment was then combined with sphingosine-1-phosphate receptor-1/2 antagonist VPC23019 or sphingosine kinase 1/2 antagonist N,N-dimethylsphingosine. RESULTS - Brain protein expression of sphingosine kinase-1 and phosphorylated Akt were significantly increased after isoflurane post-treatment, and cleaved caspase-3 was decreased at 24 hours after surgery, which was reversed by the antagonists. Isoflurane significantly reduced posthemorrhagic ventricular dilation and improved motor, but not cognitive, functions in GMH animals 3 weeks after surgery; no improvements were observed after VPC23019 administration. CONCLUSIONS - Isoflurane post-treatment improved the neurological sequelae after GMH possibly by activation of the sphingosine kinase/Akt pathway. © 2013 American Heart Association, Inc.
Original languageEnglish
Pages (from-to)3587-3590
Number of pages4
JournalStroke
Volume44
Issue number12
DOIs
StatePublished - Dec 2013

ASJC Scopus Subject Areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Keywords

  • Apoptosis
  • Caspase-3
  • Isoflurane
  • Sphingosine kinase
  • Animals, Newborn
  • Isoflurane/pharmacology
  • Phosphotransferases (Alcohol Group Acceptor)/metabolism
  • Rats
  • Intracranial Hemorrhages/chemically induced
  • Proto-Oncogene Proteins c-akt/metabolism
  • Sphingosine/analogs & derivatives
  • Neuroprotective Agents/pharmacology
  • Signal Transduction/drug effects
  • Recovery of Function/drug effects
  • Brain/drug effects
  • Animals
  • Receptors, Lysosphingolipid/metabolism
  • Disease Models, Animal
  • Phosphorylation/drug effects

Cite this